Patients with ovarian cancer stage FIGO I or II (3730; 3050–5530 pg/mg protein), however, did not differ from the control group (5240; 2160–7440 pg/mg protein) in terms of GrB-PBMC expression (p = 0.8765, Mann–Whitney test). This evidence concerns the gene GZMB and ovarian cancer.